1-3 of 3
Friederike Schmitz
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Sequential Dosing of Next-Generation IMA203CD8 TCR-T-Cell Therapy Targeting PRAME in Combination with BRAF-/MEK-Inhibition in a Melanoma Patient with Progressive Disease - a Case Report

Friederike Schmitz, Martin Schumacher, Annkristin Heine, Annette Busch, Mario Heine, Julian A. Luetkens, Jennifer Landsberg, Niklas Schäfer, Oliver Ebert, Robert Zeiser, John G. Gribben, Peter Brossart, Tobias A.W. Holderried
Journal: Blood
Blood (2024) 144 (Supplement 1): 7194.
https://doi.org/10.1182/blood-2024-194461
Published: 2024
Journal Articles

Cilta-Cel Is Associated with Improved Outcomes and Distinct Cellular Dynamics Compared with Ide-Cel for Relapsed or Refractory Multiple Myeloma

Nico Gagelmann, Friedrich Stölzel, Roland Fenk, Tobias A.W. Holderried, Fabian Mueller, Natalia Tovar, Aina Oliver-Caldés, Kristin Rathje, Vladan Vucinic, Soraya Kharboutli, Ben-Niklas Bärmann, Francis A. Ayuk, Uwe Platzbecker, Anca Maria Albici, Natalie Schub, Friederike Schmitz, Cyrus Khandanpour, Marcel Teichert, Barbara Jeker, Nicolaus Kroeger, Bastian von Tresckow, Carlos Fernandez de Larrea, Thomas Pabst, Maximilian Merz
Journal: Blood
Blood (2024) 144 (Supplement 1): 2003.
https://doi.org/10.1182/blood-2024-211410
Published: 2024
Journal Articles

The Potential of E-Health in Patients after Allogeneic Stem Cell Transplantation

Friederike Schmitz, Charlotte Neuerburg, Martin Schumacher, Udo Holtick, Edgar Jost, Guido Kobbe, Ben-Niklas Bärmann, Marie-Therese Schmitz, Matthias Schmid, Peter Brossart, Martin Holderried, Tobias A.W. Holderried
Journal: Blood
Blood (2022) 140 (Supplement 1): 7966–7967.
https://doi.org/10.1182/blood-2022-160320
Published: 2022